C12N 2795/00033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2795/00033 (Use of viral protein as therapeutic agent other than vaccine) appears on 11 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 23
- Assignees
- 17
- Inventors
- 44
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 3 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 3 |
| 2018 | 3 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 5 |
| 2022 | 1 | 3 |
| 2023 | 1 | 0 |
| 2024 | 2 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microencapsulation of bacteriophages and related products28 Apr 2026US 12,611,435 B2Precisio Biotix Therapeutics, Inc.
- Antibacterial and protective bacteriophage formulations and methods for making and using them18 Jun 2024US 12,012,617 B2San Diego State University (SDSU) Foundation
- Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto6 Feb 2024US 11,890,330 B2The United States of America as represented by the Secretary of the Navy
- Treatment of topical and systemic bacterial infections10 Oct 2023US 11,779,618 B2Fixed Phage Limited
- Antibacterial and protective bacteriophage formulations and methods for making and using them4 Jan 2022US 11,214,773 B2San Diego State University (SDSU) Foundation
- Intracellular Delivery of Therapeutic Cargos and Viral RNAS by Engineered Salmonella17 Sep 2026US 2026/0272995 A1The Trustees of Columbia University in the City of New York
- Simultaneous production of structural proteins from heterologous bacteriophage in cell-free expression system2 Apr 2026US 2026/0092261 A1Technische Universität München
- Bacteriophages with improved antimicrobial activity24 Oct 2024US 2024/0352428 A1Armata Pharmaceuticals, Inc.
- Antibacterial and protective bacteriophage formulations and methods for making and using them22 Aug 2024US 2024/0279619 A1San Diego State University (Sdsu) Foundation, Dba San Diego State University Research Foundation
- Microencapsulation of bacteriophages and related products29 Dec 2022US 2022/0409683 A1Phagelux (Canada) Inc.
Most cited
By later US patents